| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | 0.0067 | 0.8 |
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | -0.0077 | 0.8 |
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | 0.0063 | 0.8 |
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | -0.0073 | 0.8 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | -0.0062 | 0.8 |
| mRNA | apicidin | CTRPv2 | pan-cancer | AAC | -0.006 | 0.8 |
| mRNA | phenformin | GDSC1000 | pan-cancer | AAC | 0.0063 | 0.8 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | -0.0086 | 0.8 |
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | 0.014 | 0.8 |